SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Roland D. Chapurlat, Harry K. Genant, Endocrinology: Adult and Pediatric, 2016,

    CrossRef

  2. 2
    Panagiota Andreopoulou, Richard S. Bockman, Management of Postmenopausal Osteoporosis, Annual Review of Medicine, 2015, 66, 1, 329

    CrossRef

  3. 3
    Chantal M.J. de Bakker, Allison R. Altman, Wei-Ju Tseng, Mary Beth Tribble, Connie Li, Abhishek Chandra, Ling Qin, X. Sherry Liu, μCT-based, in vivo dynamic bone histomorphometry allows 3D evaluation of the early responses of bone resorption and formation to PTH and alendronate combination therapy, Bone, 2015, 73, 198

    CrossRef

  4. 4
    Benjamin Z. Leder, The Parathyroids, 2015,

    CrossRef

  5. 5
    Allison R. Altman, Wei-Ju Tseng, Chantal M.J. de Bakker, Beom Kang Huh, Abhishek Chandra, Ling Qin, X. Sherry Liu, A closer look at the immediate trabecula response to combined parathyroid hormone and alendronate treatment, Bone, 2014, 61, 149

    CrossRef

  6. 6
    Felicia Cosman, Anabolic and Antiresorptive Therapy for Osteoporosis: Combination and Sequential Approaches, Current Osteoporosis Reports, 2014, 12, 4, 385

    CrossRef

  7. 7
    Jinsong Liu, Hualin Zhang, Yiwen Dong, Yifan Jin, Xiaohui Hu, Kaiyong Cai, Jianfeng Ma, Gang Wu, Bi-directionally selective bone targeting delivery for anabolic and antiresorptive drugs: A novel combined therapy for osteoporosis?, Medical Hypotheses, 2014, 83, 6, 694

    CrossRef

  8. 8
    Felicia Cosman, Combination therapy for osteoporosis: a reappraisal, BoneKEy Reports, 2014, 3,

    CrossRef

  9. 9
    Elodie Feurer, Roland Chapurlat, Emerging drugs for osteoporosis, Expert Opinion on Emerging Drugs, 2014, 19, 3, 385

    CrossRef

  10. 10
    Erik F. Eriksen, Tony M. Keaveny, Eileen R. Gallagher, John H. Krege, Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis, Bone, 2014, 67, 246

    CrossRef

  11. You have free access to this content11
    S. Scheiner, P. Pivonka, D. W. Smith, C. R. Dunstan, C. Hellmich, Mathematical modeling of postmenopausal osteoporosis and its treatment by the anti-catabolic drug denosumab, International Journal for Numerical Methods in Biomedical Engineering, 2014, 30, 1
  12. 12
    Christian Muschitz, Roland Kocijan, Astrid Fahrleitner-Pammer, Imre Pavo, Judith Haschka, Wolfgang Schima, Stylianos Kapiotis, Heinrich Resch, Overlapping and Continued Alendronate or Raloxifene Administration in Patients on Teriparatide: Effects on Areal and Volumetric Bone Mineral Density—The CONFORS Study, Journal of Bone and Mineral Research, 2014, 29, 8
  13. 13
    Yunxing Su, Single and Combined use of Human Parathyroid Hormone (PTH) (1-34) on Areal Bone Mineral Density (aBMD) in Postmenopausal Women with Osteoporosis: Evidence Based on 9 RCTs, Medical Science Monitor, 2014, 20, 2624

    CrossRef

  14. 14
    Gen Inoue, Masaki Ueno, Toshiyuki Nakazawa, Takayuki Imura, Wataru Saito, Kentaro Uchida, Seiji Ohtori, Tomoaki Toyone, Naonobu Takahira, Masashi Takaso, Teriparatide increases the insertional torque of pedicle screws during fusion surgery in patients with postmenopausal osteoporosis, Journal of Neurosurgery: Spine, 2014, 21, 3, 425

    CrossRef

  15. 15
    Felicia Cosman, Is there a role for combination therapy for osteoporosis?, Endocrine, 2013, 44, 1, 5

    CrossRef

  16. 16
    Joy N Tsai, Alexander V Uihlein, Hang Lee, Ruchit Kumbhani, Erica Siwila-Sackman, Elizabeth A McKay, Sherri-Ann M Burnett-Bowie, Robert M Neer, Benjamin Z Leder, Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial, The Lancet, 2013, 382, 9886, 50

    CrossRef

  17. 17
    William A. Bauman, Christopher P. Cardozo, Osteoporosis, 2013,

    CrossRef